Bivalirudin anticoagulation for cardiopulmonary bypass: an unusual case
Nikolaidis, Nicolas, Velissaris, Theodore and Ohri, Sunil K. (2007) Bivalirudin anticoagulation for cardiopulmonary bypass: an unusual case. Texas Heart Institute Journal, 34, (1), 115-118.
Full text not available from this repository.
The standard agent used for systemic anticoagulation during cardiopulmonary bypass is heparin. Alternative methods of anticoagulation are required for patients with heparin hypersensitivity. We present the case of a patient with heparin hypersensitivity who was anticoagulated with bivalirudin during cardiopulmonary bypass for coronary artery bypass grafting. This presented unusual challenges surrounding the monitoring of anticoagulation and the method of myocardial protection.
|Subjects:||R Medicine > RD Surgery|
|Divisions:||University Structure - Pre August 2011 > School of Medicine > Developmental Origins of Health and Disease
|Date Deposited:||06 Oct 2008|
|Last Modified:||01 Jun 2011 02:44|
|Contributors:||Nikolaidis, Nicolas (Author)
Velissaris, Theodore (Author)
Ohri, Sunil K. (Author)
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)